Molecular-Targeted Therapy of Pediatric Acute Myeloid Leukemia

Acute myeloid leukemia (AML) accounts for approximately 15–20% of all childhood leukemia cases. The overall survival of children with acute myeloid leukemia does not exceed 82%, and the 5-year event-free survival rates range from 46% to 69%. Such suboptimal outcomes are the result of numerous mutati...

Descripción completa

Detalles Bibliográficos
Autores principales: Obszański, Piotr, Kozłowska, Anna, Wańcowiat, Jakub, Twardowska, Julia, Lejman, Monika, Zawitkowska, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230975/
https://www.ncbi.nlm.nih.gov/pubmed/35745032
http://dx.doi.org/10.3390/molecules27123911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230975/
https://www.ncbi.nlm.nih.gov/pubmed/35745032
http://dx.doi.org/10.3390/molecules27123911

Ejemplares similares